25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OGEN (Oragenics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Oragenics together

I guess you are interested in Oragenics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Oragenics’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Oragenics’s Price Targets

I'm going to help you getting a better view of Oragenics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oragenics Inc

I send you an email if I find something interesting about Oragenics Inc.

1. Quick Overview

1.1. Quick analysis of Oragenics (30 sec.)










1.2. What can you expect buying and holding a share of Oragenics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.17
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-84.1%

For what price can you sell your share?

Current Price per Share
$0.19
Expected price per share
$0 - $0.3199
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oragenics (5 min.)




Live pricePrice per Share (EOD)
$0.19
Intrinsic Value Per Share
$-4.17 - $-4.43
Total Value Per Share
$-4.18 - $-4.44

2.2. Growth of Oragenics (5 min.)




Is Oragenics growing?

Current yearPrevious yearGrowGrow %
How rich?-$211.8k$7.4m-$5.7m-339.1%

How much money is Oragenics making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$4.5m$1.8m70.9%
Net Profit Margin0.0%-4,116.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Oragenics (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#786 / 910

Most Revenue
#671 / 910

Most Profit
#288 / 910

Most Efficient
#249 / 910
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oragenics?

Welcome investor! Oragenics's management wants to use your money to grow the business. In return you get a share of Oragenics.

First you should know what it really means to hold a share of Oragenics. And how you can make/lose money.

Speculation

The Price per Share of Oragenics is $0.1872. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oragenics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oragenics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oragenics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-83.3%-0.12-65.7%-0.24-129.7%-0.21-111.7%-0.17-88.4%
Usd Book Value Change Per Share-0.15-81.8%-0.04-21.0%-0.11-61.2%-0.04-21.7%-0.01-6.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.0314.5%0.017.8%
Usd Total Gains Per Share-0.15-81.8%-0.04-21.0%-0.11-61.2%-0.01-7.2%0.001.3%
Usd Price Per Share0.37-0.81-3.80-1.22-1.03-
Price to Earnings Ratio-0.59--1.75--5.48--1.81--2.05-
Price-to-Total Gains Ratio-2.41--17.97--44.18--11.65--8.92-
Price to Book Ratio-37.43--1.54-15.79-3.24-4.42-
Price-to-Total Gains Ratio-2.41--17.97--44.18--11.65--8.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1872
Number of shares5341
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share-0.04-0.04
Usd Total Gains Per Share-0.04-0.01
Gains per Quarter (5341 shares)-210.16-72.24
Gains per Year (5341 shares)-840.63-288.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-841-851579-868-299
20-1681-16921157-1735-588
30-2522-25331736-2603-877
40-3363-33742315-3471-1166
50-4203-42152893-4338-1455
60-5044-50563472-5206-1744
70-5884-58974051-6074-2033
80-6725-67384630-6941-2322
90-7566-75795208-7809-2611
100-8406-84205787-8677-2900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.087.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.010.01.08.3%4.015.01.020.0%11.028.01.027.5%26.058.03.029.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%7.00.013.035.0%11.00.029.027.5%11.00.076.012.6%
Total Gains per Share1.03.00.025.0%1.010.01.08.3%5.014.01.025.0%12.027.01.030.0%27.057.03.031.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oragenics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.153-0.039-74%-0.115-25%-0.041-73%-0.012-92%
Book Value Per Share---0.0100.079-112%0.348-103%0.634-102%0.524-102%
Current Ratio--0.8741.667-48%5.943-85%10.299-92%8.783-90%
Debt To Asset Ratio--1.1440.580+97%0.200+471%0.218+424%0.258+343%
Debt To Equity Ratio---0.520-100%0.271-100%0.229-100%0.659-100%
Dividend Per Share----0%-0%0.027-100%0.015-100%
Enterprise Value--7111273.29017675639.663-60%86820461.520-92%37865837.297-81%31769586.428-78%
Eps---0.156-0.123-21%-0.243+56%-0.209+34%-0.165+6%
Ev To Ebitda Ratio---0.533-1.795+237%-21.987+4028%-5.771+984%-4.223+693%
Ev To Sales Ratio--infinfnan%767.600+inf%infnan%infnan%
Free Cash Flow Per Share---0.094-0.100+6%-0.089-6%-0.144+54%-0.120+28%
Free Cash Flow To Equity Per Share---0.106-0.030-71%-0.085-20%-0.039-63%-0.012-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.435--------
Intrinsic Value_10Y_min---4.173--------
Intrinsic Value_1Y_max---0.475--------
Intrinsic Value_1Y_min---0.481--------
Intrinsic Value_3Y_max---1.404--------
Intrinsic Value_3Y_min---1.399--------
Intrinsic Value_5Y_max---2.305--------
Intrinsic Value_5Y_min---2.260--------
Market Cap4020176.160-97%7930828.29017343989.163-54%81571779.520-90%26240776.447-70%22069628.928-64%
Net Profit Margin----0%-41.1680%-38.4770%-20.4980%
Operating Margin----0%-39.2760%-39.0710%-20.8580%
Operating Ratio----0%40.464-100%38.739-100%20.811-100%
Pb Ratio-18.973+49%-37.430-1.538-96%15.793-337%3.236-1257%4.416-948%
Pe Ratio-0.300+49%-0.592-1.750+196%-5.476+825%-1.806+205%-2.048+246%
Price Per Share0.187-97%0.3690.808-54%3.798-90%1.222-70%1.028-64%
Price To Free Cash Flow Ratio-0.498+49%-0.982-2.040+108%-13.037+1227%-3.475+254%-3.079+213%
Price To Total Gains Ratio-1.222+49%-2.411-17.974+645%-44.184+1733%-11.651+383%-8.924+270%
Quick Ratio--0.5131.312-61%4.732-89%9.410-95%8.088-94%
Return On Assets---2.274-1.073-53%-0.800-65%-0.542-76%-0.434-81%
Return On Equity----0.8680%-1.1930%-0.6060%-0.6660%
Total Gains Per Share---0.153-0.039-74%-0.115-25%-0.014-91%0.002-6582%
Usd Book Value---211885.0001704340.750-112%7483062.500-103%13621202.200-102%11247923.300-102%
Usd Book Value Change Per Share---0.153-0.039-74%-0.115-25%-0.041-73%-0.012-92%
Usd Book Value Per Share---0.0100.079-112%0.348-103%0.634-102%0.524-102%
Usd Dividend Per Share----0%-0%0.027-100%0.015-100%
Usd Enterprise Value--7111273.29017675639.663-60%86820461.520-92%37865837.297-81%31769586.428-78%
Usd Eps---0.156-0.123-21%-0.243+56%-0.209+34%-0.165+6%
Usd Free Cash Flow---2018353.000-2149345.500+6%-1904614.750-6%-3101939.750+54%-2574743.750+28%
Usd Free Cash Flow Per Share---0.094-0.100+6%-0.089-6%-0.144+54%-0.120+28%
Usd Free Cash Flow To Equity Per Share---0.106-0.030-71%-0.085-20%-0.039-63%-0.012-88%
Usd Market Cap4020176.160-97%7930828.29017343989.163-54%81571779.520-90%26240776.447-70%22069628.928-64%
Usd Price Per Share0.187-97%0.3690.808-54%3.798-90%1.222-70%1.028-64%
Usd Profit---3349123.000-2641979.000-21%-4513950.750+35%-4249246.900+27%-3398031.100+1%
Usd Revenue----0%28624.250-100%23226.300-100%60678.525-100%
Usd Total Gains Per Share---0.153-0.039-74%-0.115-25%-0.014-91%0.002-6582%
 EOD+2 -6MRQTTM+8 -23YOY+10 -245Y+12 -2410Y+12 -24

3.3 Fundamental Score

Let's check the fundamental score of Oragenics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.300
Price to Book Ratio (EOD)Between0-1-18.973
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.513
Current Ratio (MRQ)Greater than10.874
Debt to Asset Ratio (MRQ)Less than11.144
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.274
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Oragenics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.482
Ma 20Greater thanMa 500.247
Ma 50Greater thanMa 1000.271
Ma 100Greater thanMa 2000.304
OpenGreater thanClose0.209
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Oragenics Inc

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Fundamental data was last updated by Penke on 2025-04-02 04:41:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Oragenics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oragenics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-4,116.8%+4,116.8%
TTM-5Y-3,847.7%+3,847.7%
5Y-3,847.7%10Y-2,049.8%-1,797.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.6%+109.6%
TTM--185.9%+185.9%
YOY-4,116.8%-206.2%-3,910.6%
5Y-3,847.7%-408.8%-3,438.9%
10Y-2,049.8%-522.9%-1,526.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Oragenics is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • -227.4% Return on Assets means thatΒ Oragenics generatedΒ $-2.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oragenics Inc:

  • The MRQ is -227.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -107.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-227.4%TTM-107.3%-120.1%
TTM-107.3%YOY-80.0%-27.3%
TTM-107.3%5Y-54.2%-53.1%
5Y-54.2%10Y-43.4%-10.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-227.4%-14.2%-213.2%
TTM-107.3%-14.6%-92.7%
YOY-80.0%-14.4%-65.6%
5Y-54.2%-15.5%-38.7%
10Y-43.4%-18.0%-25.4%
4.3.1.3. Return on Equity

Shows how efficient Oragenics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Oragenics generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oragenics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-86.8%+86.8%
TTM-86.8%YOY-119.3%+32.5%
TTM-86.8%5Y-60.6%-26.2%
5Y-60.6%10Y-66.6%+6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.6%+17.6%
TTM-86.8%-18.2%-68.6%
YOY-119.3%-19.1%-100.2%
5Y-60.6%-24.3%-36.3%
10Y-66.6%-26.0%-40.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oragenics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Oragenics is operatingΒ .

  • Measures how much profit Oragenics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oragenics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3,927.6%+3,927.6%
TTM-5Y-3,907.1%+3,907.1%
5Y-3,907.1%10Y-2,085.8%-1,821.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.7%+223.7%
TTM--281.1%+281.1%
YOY-3,927.6%-226.6%-3,701.0%
5Y-3,907.1%-393.8%-3,513.3%
10Y-2,085.8%-503.6%-1,582.2%
4.3.2.2. Operating Ratio

Measures how efficient Oragenics is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oragenics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY40.464-40.464
TTM-5Y38.739-38.739
5Y38.73910Y20.811+17.929
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.324-2.324
TTM-3.192-3.192
YOY40.4643.069+37.395
5Y38.7395.133+33.606
10Y20.8117.010+13.801
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oragenics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oragenics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.87Β means the company has $0.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oragenics Inc:

  • The MRQ is 0.874. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.667. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.874TTM1.667-0.793
TTM1.667YOY5.943-4.276
TTM1.6675Y10.299-8.632
5Y10.29910Y8.783+1.516
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8743.776-2.902
TTM1.6673.930-2.263
YOY5.9434.470+1.473
5Y10.2995.748+4.551
10Y8.7836.099+2.684
4.4.3.2. Quick Ratio

Measures if Oragenics is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.51Β means the company can pay off $0.51 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oragenics Inc:

  • The MRQ is 0.513. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.312. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.513TTM1.312-0.798
TTM1.312YOY4.732-3.420
TTM1.3125Y9.410-8.098
5Y9.41010Y8.088+1.322
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5133.102-2.589
TTM1.3123.367-2.055
YOY4.7324.358+0.374
5Y9.4105.731+3.679
10Y8.0886.427+1.661
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oragenics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OragenicsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Oragenics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.14Β means that Oragenics assets areΒ financed with 114.4% credit (debt) and the remaining percentage (100% - 114.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Oragenics Inc:

  • The MRQ is 1.144. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.580. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ1.144TTM0.580+0.564
TTM0.580YOY0.200+0.380
TTM0.5805Y0.218+0.362
5Y0.21810Y0.258-0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1440.340+0.804
TTM0.5800.340+0.240
YOY0.2000.318-0.118
5Y0.2180.364-0.146
10Y0.2580.393-0.135
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Oragenics is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oragenics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.520-0.520
TTM0.520YOY0.271+0.249
TTM0.5205Y0.229+0.291
5Y0.22910Y0.659-0.430
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.399-0.399
TTM0.5200.407+0.113
YOY0.2710.389-0.118
5Y0.2290.428-0.199
10Y0.6590.460+0.199
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Oragenics generates.

  • Above 15 is considered overpriced butΒ always compareΒ Oragenics to theΒ Biotechnology industry mean.
  • A PE ratio of -0.59 means the investor is paying $-0.59Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oragenics Inc:

  • The EOD is -0.300. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.592. Based on the earnings, the company is expensive. -2
  • The TTM is -1.750. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.300MRQ-0.592+0.292
MRQ-0.592TTM-1.750+1.158
TTM-1.750YOY-5.476+3.726
TTM-1.7505Y-1.806+0.056
5Y-1.80610Y-2.048+0.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.300-1.736+1.436
MRQ-0.592-2.674+2.082
TTM-1.750-3.229+1.479
YOY-5.476-3.337-2.139
5Y-1.806-6.386+4.580
10Y-2.048-7.280+5.232
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oragenics Inc:

  • The EOD is -0.498. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.982. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.040. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.498MRQ-0.982+0.484
MRQ-0.982TTM-2.040+1.057
TTM-2.040YOY-13.037+10.997
TTM-2.0405Y-3.475+1.435
5Y-3.47510Y-3.079-0.396
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.498-2.257+1.759
MRQ-0.982-3.660+2.678
TTM-2.040-4.254+2.214
YOY-13.037-4.479-8.558
5Y-3.475-8.682+5.207
10Y-3.079-9.845+6.766
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Oragenics is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -37.43 means the investor is paying $-37.43Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oragenics Inc:

  • The EOD is -18.973. Based on the equity, the company is expensive. -2
  • The MRQ is -37.430. Based on the equity, the company is expensive. -2
  • The TTM is -1.538. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.973MRQ-37.430+18.456
MRQ-37.430TTM-1.538-35.892
TTM-1.538YOY15.793-17.331
TTM-1.5385Y3.236-4.774
5Y3.23610Y4.416-1.180
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.9731.641-20.614
MRQ-37.4302.266-39.696
TTM-1.5382.443-3.981
YOY15.7932.468+13.325
5Y3.2363.790-0.554
10Y4.4164.287+0.129
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oragenics Inc.

4.8.3. Insider Transactions

Insiders are holding 13.3% of the shares of Oragenics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-06-17Telling FredBUY100840.291010000
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Total Stockholder Equity 3,168-5432,625-1,2991,3261,7513,078-3,289-212
Net Working Capital  2,068-5331,535-1,2992361,7511,987-2,199-212



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,473
Total Liabilities1,684
Total Stockholder Equity-212
 As reported
Total Liabilities 1,684
Total Stockholder Equity+ -212
Total Assets = 1,473

Assets

Total Assets1,473
Total Current Assets1,473
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 865
Other Current Assets 608
Total Current Assets  (as reported)1,473
Total Current Assets  (calculated)1,473
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,684
Long-term Liabilities0
Total Stockholder Equity-212
Total Current Liabilities
Short-term Debt 329
Short Long Term Debt 329
Accounts payable 1,145
Other Current Liabilities 211
Total Current Liabilities  (as reported)1,684
Total Current Liabilities  (calculated)2,013
+/- 329
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock13
Retained Earnings -216,786
Other Stockholders Equity 216,562
Total Stockholder Equity (as reported)-212
Total Stockholder Equity (calculated)-212
+/-0
Other
Capital Stock13
Cash and Short Term Investments 865
Common Stock Shares Outstanding 6,622
Liabilities and Stockholders Equity 1,473
Net Debt -536
Net Invested Capital 117
Net Working Capital -212
Short Long Term Debt Total 329



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-31
> Total Assets 
0
1,939
1,821
3,651
6,101
5,369
4,808
4,466
3,794
3,096
2,156
2,146
1,906
1,969
1,470
1,606
1,593
1,069
1,735
1,151
2,553
4,264
3,267
1,594
1,594
2,127
1,080
3,203
2,228
1,678
2,641
1,728
1,178
1,307
1,229
1,267
1,267
1,983
12,584
10,488
8,823
7,071
8,815
16,831
15,141
13,337
12,303
11,132
9,761
8,695
7,390
5,778
3,957
6,137
5,396
4,309
2,351
4,577
5,135
7,215
5,494
5,209
15,536
22,050
31,309
26,933
23,652
19,753
15,562
10,732
11,282
18,681
37,366
35,248
31,091
28,231
22,204
18,465
15,041
14,758
14,758
8,464
7,899
4,966
3,534
2,710
5,204
1,473
1,4735,2042,7103,5344,9667,8998,46414,75814,75815,04118,46522,20428,23131,09135,24837,36618,68111,28210,73215,56219,75323,65226,93331,30922,05015,5365,2095,4947,2155,1354,5772,3514,3095,3966,1373,9575,7787,3908,6959,76111,13212,30313,33715,14116,8318,8157,0718,82310,48812,5841,9831,2671,2671,2291,3071,1781,7282,6411,6782,2283,2031,0802,1271,5941,5943,2674,2642,5531,1511,7351,0691,5931,6061,4701,9691,9062,1462,1563,0963,7944,4664,8085,3696,1013,6511,8211,9390
   > Total Current Assets 
0
1,913
1,784
3,608
6,039
5,294
4,502
3,775
2,590
1,861
987
1,050
882
1,015
585
781
831
376
1,107
592
2,094
3,850
2,884
1,271
1,271
1,952
963
3,127
2,165
1,619
2,413
1,499
970
1,119
1,061
1,118
1,118
1,871
12,491
10,404
8,759
7,023
8,777
16,805
15,102
13,305
12,277
11,023
9,594
8,525
7,231
5,638
3,835
6,033
5,288
4,222
2,281
4,526
5,101
7,193
5,480
5,198
15,472
21,933
31,073
26,075
22,847
18,838
14,701
9,925
10,529
17,983
36,724
34,662
30,535
27,707
21,650
17,970
14,513
14,290
14,290
8,099
7,814
3,866
2,443
1,619
4,113
1,473
1,4734,1131,6192,4433,8667,8148,09914,29014,29014,51317,97021,65027,70730,53534,66236,72417,98310,5299,92514,70118,83822,84726,07531,07321,93315,4725,1985,4807,1935,1014,5262,2814,2225,2886,0333,8355,6387,2318,5259,59411,02312,27713,30515,10216,8058,7777,0238,75910,40412,4911,8711,1181,1181,0611,1199701,4992,4131,6192,1653,1279631,9521,2711,2712,8843,8502,0945921,1073768317815851,0158821,0509871,8612,5903,7754,5025,2946,0393,6081,7841,9130
       Cash And Cash Equivalents 
0
1,868
1,693
3,584
6,012
5,146
4,314
3,666
2,381
1,682
852
938
726
862
470
707
750
151
936
476
1,967
3,634
2,700
1,166
1,166
1,820
725
302
459
217
505
132
56
441
383
172
172
1,130
11,758
9,926
8,350
6,368
8,268
16,277
14,639
12,899
11,765
10,449
9,053
8,044
6,739
5,083
3,368
5,457
5,117
4,081
2,175
2,089
2,923
6,166
4,758
3,941
13,811
20,208
29,349
25,720
22,292
18,268
14,372
9,629
10,044
17,640
36,501
34,575
29,949
27,266
21,372
17,867
13,951
11,427
11,427
6,474
5,767
3,484
2,072
1,349
3,144
865
8653,1441,3492,0723,4845,7676,47411,42711,42713,95117,86721,37227,26629,94934,57536,50117,64010,0449,62914,37218,26822,29225,72029,34920,20813,8113,9414,7586,1662,9232,0892,1754,0815,1175,4573,3685,0836,7398,0449,05310,44911,76512,89914,63916,2778,2686,3688,3509,92611,7581,130172172383441561325052174593027251,8201,1661,1662,7003,6341,9674769361517507074708627269388521,6822,3813,6664,3145,1466,0123,5841,6931,8680
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,450
896
742
555
476
389
441
383
265
294
195
144
62
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,919
1,408
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
0
0
0
0
0
0
0
0000000180000000000000000000001,4081,919000000000000000026621441952942653834413894765557428962,450000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
20
10
163
222
174
212
485
96
55
44
93
93
39
72
70
55
50
59
64
43
23
26
16
30
27
19
21
33
450
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
0
0
13
35
0
0
0
0
0
00000351300777700000000000000000000045033211927301626234364595055707239939344559648521217422216310206600000000000000000000000
       Other Current Assets 
0
45
91
25
27
148
187
109
209
179
135
112
156
154
0
74
81
225
171
117
127
216
184
88
87
70
114
2,531
1,206
813
459
616
543
563
551
113
378
348
381
284
236
302
227
175
154
145
222
119
134
90
173
212
193
125
172
141
106
2,437
2,178
1,027
723
1,257
1,661
1,725
1,724
355
555
570
329
295
486
343
223
87
587
435
277
102
562
2,863
2,863
1,612
2,012
382
371
270
969
608
6089692703713822,0121,6122,8632,863562102277435587872233434862953295705553551,7241,7251,6611,2577231,0272,1782,437106141172125193212173901341192221451541752273022362843813483781135515635436164598131,2062,53111470878818421612711717122581740154156112135179209109187148272591450
   > Long-term Assets 
0
25
37
42
61
75
307
691
1,204
1,235
1,169
1,097
1,024
954
886
825
762
693
628
559
459
414
383
0
323
175
117
75
63
59
227
228
208
188
168
149
149
111
93
85
64
49
38
27
39
32
26
109
168
171
159
141
122
104
107
87
69
52
34
22
14
11
64
116
236
858
805
915
861
807
753
698
642
586
556
524
554
495
528
469
469
366
85
1,101
1,091
1,091
1,091
0
01,0911,0911,0911,10185366469469528495554524556586642698753807861915805858236116641114223452698710710412214115917116810926323927384964859311114914916818820822822759637511717532303834144595596286937628258869541,0241,0971,1691,2351,20469130775614237250
       Property Plant Equipment 
0
25
37
42
61
75
307
691
1,204
1,235
1,169
1,097
1,024
954
886
825
762
693
628
559
459
414
383
323
323
175
117
75
63
59
227
228
208
188
168
149
149
111
93
85
64
49
38
27
39
32
26
109
168
171
159
141
122
104
107
87
69
52
34
22
14
11
64
116
236
858
805
915
861
807
753
698
642
586
556
524
554
495
528
469
469
348
77
10
0
0
0
0
0000107734846946952849555452455658664269875380786191580585823611664111422345269871071041221411591711681092632392738496485931111491491681882082282275963751171753233233834144595596286937628258869541,0241,0971,1691,2351,20469130775614237250
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
655
0
0
0
0
0
0
0
0
0
18
9
0
0
0
0
0
0000091800000000065500000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
334
236
211
210
212
327
430
834
812
765
375
368
400
325
328
362
375
248
331
398
365
474
1,771
1,771
3,415
1,973
563
642
1,760
2,465
3,627
4,518
6,293
7,810
9,446
9,446
3,432
1,753
1,256
1,174
1,388
4,453
993
938
778
740
796
606
5,601
5,887
1,047
1,083
898
909
1,343
1,165
4,072
4,122
899
1,179
1,558
1,557
1,168
2,185
2,510
2,833
2,521
2,653
1,944
1,642
1,836
1,315
2,514
2,545
1,745
1,663
1,678
1,703
1,749
1,749
1,207
1,402
1,798
909
1,383
2,127
1,684
1,6842,1271,3839091,7981,4021,2071,7491,7491,7031,6781,6631,7452,5452,5141,3151,8361,6421,9442,6532,5212,8332,5102,1851,1681,5571,5581,1798994,1224,0721,1651,3439098981,0831,0475,8875,6016067967407789389934,4531,3881,1741,2561,7533,4329,4469,4467,8106,2934,5183,6272,4651,7606425631,9733,4151,7711,7714743653983312483753623283254003683757658128344303272122102112363340
   > Total Current Liabilities 
0
334
236
211
210
212
327
430
470
438
765
375
368
400
325
328
362
375
248
331
398
365
474
1,771
1,771
2,415
973
563
642
1,760
2,465
1,627
1,518
1,793
7,810
9,446
9,446
1,376
1,753
1,256
1,174
1,388
4,453
993
938
778
740
796
606
5,601
5,887
1,047
1,083
898
909
1,343
1,165
1,084
1,722
899
1,179
1,558
1,557
1,168
2,185
1,894
2,247
1,850
2,025
1,360
1,102
1,342
869
2,116
2,196
1,445
1,409
1,460
1,498
1,596
1,596
1,141
1,402
1,798
909
1,383
2,127
1,684
1,6842,1271,3839091,7981,4021,1411,5961,5961,4981,4601,4091,4452,1962,1168691,3421,1021,3602,0251,8502,2471,8942,1851,1681,5571,5581,1798991,7221,0841,1651,3439098981,0831,0475,8875,6016067967407789389934,4531,3881,1741,2561,7531,3769,4469,4467,8101,7931,5181,6272,4651,7606425639732,4151,7711,7714743653983312483753623283254003683757654384704303272122102112363340
       Short-term Debt 
0
85
85
0
0
0
0
0
193
194
521
0
0
0
0
0
0
0
0
0
0
69
53
28
28
132
72
35
60
1,030
159
99
109
66
6,104
7,553
7,553
35
88
48
67
142
108
64
80
36
110
65
79
35
5,110
63
79
35
112
66
63
23
128
80
68
21
190
124
210
153
353
309
239
303
646
405
296
186
672
498
315
181
627
0
472
190
518
332
127
0
519
329
329519012733251819047206271813154986721862964056463032393093531532101241902168801282363661123579635,110357965110368064108142674888357,5537,5536,10466109991591,0306035721322828536900000000005211941930000085850
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65
0
0
0
63
0
0
0
66
63
2,423
2,528
80
68
21
0
0
78
13
217
144
71
132
472
228
115
0
482
303
122
0
425
268
108
0
493
0
127
0
519
329
32951901270493010826842501223034820115228472132711442171378002168802,5282,4236366000630006500000000000000000000000000000000000000000000000
       Accounts payable 
0
181
83
141
210
212
327
430
278
244
243
375
253
235
176
328
253
288
161
331
338
253
378
494
2,583
2,283
791
194
573
679
1,291
746
1,311
1,611
1,544
1,740
631
1,255
1,399
440
1,082
1,222
2,365
249
491
696
602
484
506
549
511
384
579
536
589
461
796
446
699
618
1,049
1,537
1,367
829
1,975
1,694
1,839
1,207
1,787
1,057
457
330
573
1,930
1,523
855
1,094
1,280
871
247
247
591
809
1,245
696
1,180
1,513
1,145
1,1451,5131,1806961,2458095912472478711,2801,0948551,5231,9305733304571,0571,7871,2071,8391,6941,9758291,3671,5371,0496186994467964615895365793845115495064846026964912492,3651,2221,0824401,3991,2556311,7401,5441,6111,3117461,2916795731947912,2832,583494378253338331161288253328176235253375243244278430327212210141831810
       Other Current Liabilities 
0
46
45
70
0
0
0
0
0
0
0
0
116
165
150
0
110
87
87
0
60
43
43
1,249
1,744
2,283
791
284
573
679
1,000
1,515
1,312
1,611
1,544
153
1,083
1,255
1,399
692
1,082
1,222
1,956
661
316
8
3
227
3
5,000
250
586
408
327
209
816
306
615
895
200
62
1,537
1,367
215
132
47
56
499
1,787
1,057
457
784
573
1,930
1,523
93
1,094
1,280
948
0
878
951
884
221
86
203
94
211
211942038622188495187809481,2801,094931,5231,9305737844571,0571,78749956471322151,3671,537622008956153068162093274085862505,0003227383166611,9561,2221,0826921,3991,2551,0831531,5441,6111,3121,5151,0006795732847912,2831,7441,249434360087871100150165116000000007045460
   > Long-term Liabilities 
0
267
168
141
210
212
327
430
364
374
765
375
253
235
176
328
253
288
161
331
338
323
431
0
28
1,000
1,000
279
68
1,081
174
2,000
3,000
4,500
6,266
0
8,363
2,056
354
565
91
165
2,497
332
131
75
135
570
97
601
5,125
461
96
35
112
528
63
2,988
2,400
699
68
1,558
1,557
953
2,053
616
586
671
628
584
539
494
446
398
349
300
254
217
205
152
152
66
0
0
782
0
1,607
0
01,607078200661521522052172543003493984464945395846286715866162,0539531,5571,558686992,4002,9886352811235964615,12560197570135751313322,497165915653542,0568,36306,2664,5003,0002,0001741,081682791,0001,0002804313233383311612882533281762352533757653743644303272122101411682670
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,500
0
0
774
2,056
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000002,056774004,500000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
588
2,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000002,400588000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000588000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
1,604
1,584
3,440
5,891
5,158
4,481
4,036
2,960
2,283
1,391
1,772
1,538
1,569
1,145
1,278
1,230
695
1,487
820
2,155
3,899
2,793
0
-177
-1,288
-893
2,640
1,587
-82
176
-1,899
-3,339
-4,985
-6,581
-8,179
-8,179
-1,449
10,831
9,232
7,649
5,683
4,362
15,839
14,203
12,559
11,564
10,336
9,156
3,094
1,503
4,731
2,874
5,239
4,486
2,966
1,186
505
1,013
6,316
4,315
3,651
13,979
20,882
29,124
24,423
20,819
17,232
12,909
8,788
9,640
16,845
36,050
32,733
28,546
26,486
20,541
16,787
13,338
13,009
13,009
7,257
6,497
3,168
2,625
1,326
3,078
-212
-2123,0781,3262,6253,1686,4977,25713,00913,00913,33816,78720,54126,48628,54632,73336,05016,8459,6408,78812,90917,23220,81924,42329,12420,88213,9793,6514,3156,3161,0135051,1862,9664,4865,2392,8744,7311,5033,0949,15610,33611,56412,55914,20315,8394,3625,6837,6499,23210,831-1,449-8,179-8,179-6,581-4,985-3,339-1,899176-821,5872,640-893-1,288-17702,7933,8992,1558201,4876951,2301,2781,1451,5691,5381,7721,3912,2832,9604,0364,4815,1585,8913,4401,5841,6040
   Common Stock
0
12
12
13
14
14
14
15
15
15
15
18
20
21
21
22
23
23
28
28
33
38
38
38
38
90
91
106
108
108
6
6
6
6
6
6
6
17
27
27
27
28
30
36
36
36
36
36
36
36
36
40
40
49
49
49
49
49
49
5
5
6
18
29
46
46
46
46
46
55
61
92
116
116
116
116
116
116
117
2
2
2
3
3
4
6
9
13
13964332221171161161161161161169261554646464646291865549494949494940403636363636363636302827272717666666610810810691903838383833282823232221212018151515151414141312120
   Retained Earnings Total Equity00000000000000-164,598-160,782-154,445-150,036-145,539-133,202-127,353-123,756-119,919-115,113-111,374-108,618-105,860-103,579-101,401-99,940-97,873-96,652-94,669-91,994-90,031-89,719-87,656-85,437-83,573-77,237-75,945-74,721-73,692-71,796-70,155-67,076-57,750-55,676-54,086-52,098-49,542-42,613-40,996-39,057-37,249000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00-1,593-1,593-3-1,593-1,593000000000000-1,664-1,664000-1,615000-1,584000-1,519-1,015-2,000-1,448-1,448000-1,557000-1,53000-1,453-1,45300-1,378-1,37800-1,299-1,29900-1,257-1,25700-1,074-1,074-870-870-870-870-596-596-596-596-316-316-316-316-59-59-59-59-17-17-17-17000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,258
32,470
32,811
42,286
48,076
62,901
63,291
63,298
63,406
71,408
85,958
85,963
86,214
86,248
86,245
86,357
86,631
86,903
92,347
92,553
97,222
97,447
97,616
97,788
97,847
99,658
101,403
101,789
103,404
115,765
126,126
137,677
137,782
138,015
138,025
138,890
147,097
152,440
164,023
194,061
194,558
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000194,558194,061164,023152,440147,097138,890138,025138,015137,782137,677126,126115,765103,404101,789101,40399,65897,84797,78897,61697,44797,22292,55392,34786,90386,63186,35786,24586,24886,21485,96385,95871,40863,40663,29863,29162,90148,07642,28632,81132,47032,258000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,962
3,339
5,837
8,825
8,759
8,697
9,552
9,342
9,538
9,397
10,793
11,414
12,241
12,376
13,511
14,004
14,064
15,339
15,632
17,755
20,588
20,620
0
20,851
21,464
23,295
29,302
28,738
29,079
31,314
32,711
31,531
32,258
32,470
0
34,189
48,076
62,901
64,744
63,298
63,406
71,408
87,487
85,963
86,214
86,248
87,802
86,357
86,631
86,903
93,795
92,553
97,222
97,447
99,105
97,788
97,847
99,658
102,987
101,789
103,404
115,765
127,741
137,677
137,782
138,015
139,689
138,890
147,097
152,440
164,023
194,061
194,558
194,755
194,987
195,077
195,356
196,888
0
196,977
198,713
199,966
207,791
209,697
210,702
214,913
216,562
216,562214,913210,702209,697207,791199,966198,713196,9770196,888195,356195,077194,987194,755194,558194,061164,023152,440147,097138,890139,689138,015137,782137,677127,741115,765103,404101,789102,98799,65897,84797,78899,10597,44797,22292,55393,79586,90386,63186,35787,80286,24886,21485,96387,48771,40863,40663,29864,74462,90148,07634,189032,47032,25831,53132,71131,31429,07928,73829,30223,29521,46420,851020,62020,58817,75515,63215,33914,06414,00413,51112,37612,24111,41410,7939,3979,5389,3429,5528,6978,7598,8255,8373,3392,9620



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-10,559
Operating Income-10,559-10,559
 
Operating Expense (+$)
Research Development4,114
Selling General Administrative6,444
Selling And Marketing Expenses0
Operating Expense10,55910,559
 
Net Interest Income (+$)
Interest Income46
Interest Expense-30
Other Finance Cost-0
Net Interest Income16
 
Pretax Income (+$)
Operating Income-10,559
Net Interest Income16
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,568-10,550
EBIT - interestExpense = -30
-10,568
-10,538
Interest Expense30
Earnings Before Interest and Taxes (EBIT)0-10,538
Earnings Before Interest and Taxes (EBITDA)-10,559
 
After tax Income (+$)
Income Before Tax-10,568
Tax Provision-0
Net Income From Continuing Ops-10,568-10,568
Net Income-10,568
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-9-16
 

Technical Analysis of Oragenics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oragenics. The general trend of Oragenics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oragenics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Oragenics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oragenics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.31 < 0.3181 < 0.3199.

The bearish price targets are: .

Know someone who trades $OGEN? Share this with them.πŸ‘‡

Oragenics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oragenics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oragenics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oragenics Inc. The current macd is -0.02229749.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oragenics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oragenics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oragenics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Oragenics Inc Daily Moving Average Convergence/Divergence (MACD) ChartOragenics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oragenics Inc. The current adx is 31.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Oragenics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Oragenics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oragenics Inc. The current sar is 0.28972794.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Oragenics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oragenics Inc. The current rsi is 23.48. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Oragenics Inc Daily Relative Strength Index (RSI) ChartOragenics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oragenics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oragenics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oragenics Inc Daily Stochastic Oscillator ChartOragenics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oragenics Inc. The current cci is -140.42782007.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Oragenics Inc Daily Commodity Channel Index (CCI) ChartOragenics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oragenics Inc. The current cmo is -64.60706098.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oragenics Inc Daily Chande Momentum Oscillator (CMO) ChartOragenics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oragenics Inc. The current willr is -88.91304348.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Oragenics Inc Daily Williams %R ChartOragenics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Oragenics Inc.

Oragenics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oragenics Inc. The current atr is 0.02267027.

Oragenics Inc Daily Average True Range (ATR) ChartOragenics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oragenics Inc. The current obv is 219,136,521.

Oragenics Inc Daily On-Balance Volume (OBV) ChartOragenics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oragenics Inc. The current mfi is 33.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Oragenics Inc Daily Money Flow Index (MFI) ChartOragenics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oragenics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Oragenics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oragenics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.482
Ma 20Greater thanMa 500.247
Ma 50Greater thanMa 1000.271
Ma 100Greater thanMa 2000.304
OpenGreater thanClose0.209
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oragenics with someone you think should read this too:
  • Are you bullish or bearish on Oragenics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oragenics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oragenics Inc

I send you an email if I find something interesting about Oragenics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Oragenics Inc.

Receive notifications about Oragenics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.